NCT03882437: Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B
- State
- Completed
- Phase
- Phase 1
- People
- 7 taking part
- Started
- 17 Apr 2019
- Primary completion
- 3 Jul 2025
- Arms
- RP-A501
- Results
- None posted
- 20 Mar 2019: Trial registered
- 17 Apr 2019: Trial started
- 3 Jul 2025: Trial completed